Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week


Shares of several COVID-19 vaccine makers are plunging this week. BioNTech (NASDAQ: BNTX) stock is taking the worst drubbing, down 19.7% as of the market close on Thursday. Moderna's (NASDAQ: MRNA) shares were sinking 17.2%. Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) stocks were falling 18.5% and 16.2%, respectively. All of these declines are based on data from S&P Global Market Intelligence

There are multiple factors behind the sharp sell-off of these vaccine stocks. Perhaps most importantly, investors appear to be looking beyond the current surge in COVID-19 cases to a future where the demand for vaccines could be lower. The World Health Organization's (WHO) chief scientist also stated publicly on Tuesday that there's no evidence that booster doses are needed for healthy children and adolescents.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments